NCT03087487View on ClinicalTrials.gov

Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

466,991

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

February 26, 2023

Study Completion Date

March 8, 2023

Conditions
Non-Valvular Atrial Fibrillation
Trial Locations (1)

48104

Local Institution, Ann Arbor

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03087487 - Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation | Biotech Hunter | Biotech Hunter